SuperworthEnovis CORP EPS ENOV
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jul 3, 2026
- −$19.26
- Latest quarter, Q2 FY26
- −$0.02
- Fiscal year 2025
- −$20.71
Enovis CORP's earnings per share was −$19.26 over the twelve months to Jul 3, 2026.
In its latest quarter, Q2 FY26, it was −$0.02.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$20.71 | n/a |
| FY2024 | −$14.83 | n/a |
| FY2023 | −$0.61 | n/a |
| FY2022 | −$0.25 | −118% |
| FY2021 | $1.41 | +52% |
| FY2020 | $0.93 | n/a |
| FY2019 | −$1.44 | −134% |
| FY2018 | $4.26 | n/a |
| FY2017 | −$1.80 | −158% |
| FY2016 | $3.12 | −23% |
| FY2015 | $4.05 | −55% |
| FY2014 | $8.94 | +96% |
| FY2013 | $4.56 | n/a |
| FY2012 | −$3.18 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.02 | n/a | −$19.26 | |
| Q1 FY26 | −$0.15 | n/a | −$19.88 | |
| Q4 FY25 | −$9.10 | n/a | −$20.71 | |
| Q3 FY25 | −$9.99 | n/a | −$24.20 | |
| Q2 FY25 | −$0.64 | n/a | −$14.79 | |
| Q1 FY25 | −$0.98 | n/a | −$14.49 | |
| Q4 FY24 | −$12.59 | −25280% | −$14.83 | |
| Q3 FY24 | −$0.58 | n/a | −$2.19 | |
| Q2 FY24 | −$0.34 | n/a | −$1.66 | |
| Q1 FY24 | −$1.32 | n/a | −$1.50 | |
| Q4 FY23 | $0.05 | n/a | −$0.61 | |
| Q3 FY23 | −$0.05 | n/a | −$1.37 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Enovis CORP's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ENOVEnovis CORP | −$19.26 | |
| BVSBioventus | $0.77 | |
| CDRECadre | $0.81 | −14% a year |
| STAAStaar Surgical | $0.07 | |
| IRMDIradimed | $1.79 | +10% a year |
| EYENational Vision | $0.61 | |
| LMATLemaitre Vascular | $2.85 | +38% a year |
| INSPInspire Medical Systems | $4.62 | +166% a year |
| MOVMovado | $1.80 | +137% a year |
| UFPTUFP Technologies | $9.28 | +8% a year |
| MDXGMimedx | $0.04 | −81% a year |
| Peer median | $1.30 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Enovis CORP
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.